249 related articles for article (PubMed ID: 26670831)
1. Exchange Transfusion and Leukapheresis in Pediatric Patients with AML With High Risk of Early Death by Bleeding and Leukostasis.
Creutzig U; Rössig C; Dworzak M; Stary J; von Stackelberg A; Wössmann W; Zimmermann M; Reinhardt D
Pediatr Blood Cancer; 2016 Apr; 63(4):640-5. PubMed ID: 26670831
[TBL] [Abstract][Full Text] [Related]
2. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia.
Creutzig U; Ritter J; Budde M; Sutor A; Schellong G
Cancer; 1987 Dec; 60(12):3071-9. PubMed ID: 3479232
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia.
De Santis GC; de Oliveira LC; Romano LG; Almeida Prado Bde P; Simoes BP; Rego EM; Covas DT; Falcao RP
J Clin Apher; 2011; 26(4):181-5. PubMed ID: 21574176
[TBL] [Abstract][Full Text] [Related]
4. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
5. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.
Creutzig U; Zimmermann M; Reinhardt D; Dworzak M; Stary J; Lehrnbecher T
J Clin Oncol; 2004 Nov; 22(21):4384-93. PubMed ID: 15514380
[TBL] [Abstract][Full Text] [Related]
6. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
7. A rare complication of leukostasis with AML M4 patient: Microcirculatory dysfunction of upper extremities.
Ersayoğlu İ; Yazıcı Özkaya P; Metin H; Hekimci H; Zararcı K; Yılmaz Karapınar D; Karapınar B
Transfus Apher Sci; 2023 Aug; 62(4):103717. PubMed ID: 37173209
[TBL] [Abstract][Full Text] [Related]
8. [Successful induction therapy for acute myeloid leukemia complicated with brain hemorrhage and hyperleukocytosis].
Miyazaki T; Abe N; Yamazaki E; Koyama S; Miyashita K; Takahashi H; Nakajima Y; Tachibana T; Kamijo A; Tomita N; Ishigastubo Y
Rinsho Ketsueki; 2016 Feb; 57(2):180-5. PubMed ID: 26935637
[TBL] [Abstract][Full Text] [Related]
9. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
Cline A; Jajosky R; Shikle J; Bollag R
J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
[TBL] [Abstract][Full Text] [Related]
10. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
[TBL] [Abstract][Full Text] [Related]
11. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
12. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Malkan UY; Ozcebe OI
Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
[TBL] [Abstract][Full Text] [Related]
13. Management of Hyperleukocytosis in Childhood Acute Leukemia Without Leukapheresis and Rasburicase Prophylaxis.
Aylan Gelen S; Sarper N; Zengin E; Azizoğlu M
J Pediatr Hematol Oncol; 2022 Jan; 44(1):12-18. PubMed ID: 34054042
[TBL] [Abstract][Full Text] [Related]
14. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
15. The role of therapeutic leukapheresis in hyperleukocytotic AML.
Pastore F; Pastore A; Wittmann G; Hiddemann W; Spiekermann K
PLoS One; 2014; 9(4):e95062. PubMed ID: 24733550
[TBL] [Abstract][Full Text] [Related]
16. Genetic mutations and leukapheresis in acute myeloid leukemia: is there a link?
Corbingi A; Putzulu R; Massini G; Colangelo M; Minnella G; Chiusolo P; Sica S; Piccirillo N
Ann Hematol; 2023 Oct; 102(10):2735-2740. PubMed ID: 37592090
[TBL] [Abstract][Full Text] [Related]
17. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
[TBL] [Abstract][Full Text] [Related]
18. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
19. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
20. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP; Zeidan AM
Cells; 2020 Oct; 9(10):. PubMed ID: 33080779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
